Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. H. van Rijt, C. Argyo, D. A. Bölükbas, O. Eickelberg, T. Bein, S. Meiners (Munich, Germany). Mesoporous silica-based nanoparticles for targeted delivery of proteasome inhibitors to the lung. Eur Respir J 2013; 42: Suppl. 57, 221

Member's Comments

No comment yet.

Related content which might interest you: Combinatorial delivery of targeted mesoporous silica nanoparticles for lung cancer therapy Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 MMP-9 responsive mesoporous silica nanoparticles for local drug delivery to NSCLC cells Source: International Congress 2014 – Thoracic tumours: news from the lab Year: 2014 Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Effect of avidin protein coated and uncoated mesoporous silica drug nanocarriers on their bioresponse in the lung Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Use of decellularized tracheas for airways engineering Source: International Congress 2016 – Current challenges in thoracic surgery Year: 2016 Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Antitumor efficacy of the double suicide genesin lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Cetuximab administered through pulmonary route in a mice model of lung tumor Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 CK2 enzyme affinity against c-myc424-434 substrate in human lung cancer tissue Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Cox-2 inhibitors in the treatment of small cell lung cancer patients Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 A polypeptide of the megakaryocyte potentiating factor is a potential biomarker in plasma for the detection of mesothelioma Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015